Clinical trial Recruiting at 1 site Observational Ages 18 and up

A method to predict radiation-induced mouth sores in cancer patients

Official title: The Prediction of a Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis in Patients With Nasopharyngeal Carcinoma: an Observational Study

Run by Nanfang Hospital, Southern Medical University · NCT06287788 · Data updated 2026-11-12

This study is testing a new way to predict if cancer patients receiving radiation for throat cancer will develop painful mouth sores, to help improve their treatment experience.

More Radiation-induced Oral Mucositis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorNanfang Hospital, Southern Medical University
Academic / other
Drugs / interventionsradiation
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedOctober 30, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 1, 2024
Trial IDNCT06287788 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with histologically confirmed nasopharyngeal carcinoma currently receiving radical radiotherapy or chemoradiotherapy.

Probably not a fit

Patients with poor oral hygiene, untreated dental diseases, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate a new mucosal contouring method based on swallowing-induced breakthrough pain to predict the occurrence of radiation-induced oropharyngeal mucositis in patients with nasopharyngeal carcinoma. The study will involve multiple centers and focus on patients undergoing radical radiotherapy or chemoradiotherapy. By identifying high-risk patients through this innovative predictive model, the study seeks to improve patient outcomes and quality of life. The researchers will analyze the effectiveness of this method compared to traditional contouring approaches.

Why it matters

Potential benefit: If successful, this study could lead to better prediction and management of severe oropharyngeal mucositis, improving the quality of life for patients undergoing treatment for nasopharyngeal carcinoma.

How similar studies have gone: While traditional methods have shown limited success, this novel approach based on swallowing-induced pain has demonstrated better predictive performance in preliminary results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provide informed written consent.
2. Age ≥ 18 years.
3. Histologically confirmed as nasopharyngeal carcinoma, and currently undergoing radical radiotherapy or chemoradiotherapy.
4. Complete and continuous records of oral / oropharyngeal mucositis grading, and self-reported swallowing-induced breakthrough pain.

Exclusion Criteria:

1. Existence of poor oral hygiene, untreated dental or periodontal diseases, and metal dental restorations.
2. Current untreated or unresolved conditions like unstable heart diseases requiring treatment, and poorly controlled diabetes mellitus.
3. Body mass index (BMI) \<18.5.
4. Unsuitable to participate in current study, according to researchers' assessment.

Where it's running

  • Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Jian Guan, Ph.D. — Nanfang Hospital, Southern Medical University
  • Study coordinator: Jian Guan, Ph.D.
  • Email: guanjian5461@163.com
  • Phone: +86-13632102247

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.